• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄膜黑色素瘤中免疫相关预后模型的构建及CEBPB的功能分析:一项符合STROBE标准的观察性研究。

Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational study.

作者信息

Tao Yulin, Peng Yirui, Zhu Haibo, Xiong Minqi, Zhou Qiong, Ouyang Jun

机构信息

Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, P. R. China.

Department of Ophthalmology, Jiujiang No. 1 People's Hospital, Jiujiang, Jiangxi Province, P. R. China.

出版信息

Medicine (Baltimore). 2025 Jun 20;104(25):e42574. doi: 10.1097/MD.0000000000042574.

DOI:10.1097/MD.0000000000042574
PMID:40550050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12187318/
Abstract

Uveal melanoma (UM) is a primary intraocular malignancy with a high-risk of metastasis. Currently, there are no studies that construct prognostic models based on immune-related molecular subtypes. We performed unsupervised clustering of immune cell infiltration matrices based on the the cancer genome atlas-uveal melanoma (TCGA-UVM) dataset, identifying 2 clusters with distinct expression patterns of immune checkpoint and immune activation related genes. gene ontology/Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed that genes in the immune-related gene modules identified by WGCNA were associated with immune activity and cell proliferation. Using Cox and LASSO regression analysis based on the immune-related gene modules to construct a prognostic model. The prognostic model was validated in external datasets of Gene Expression Omnibus (GEO) database. We constructed a prognostic model comprising genes S100A4, KCNIP3, PARP8, ORAI2, MMP12, ISG20, MMP9, and CEBPB. The model stratified patients into high and low-risk groups, with the high-risk group showing poorer prognosis. The model's predictive accuracy was validated with the AUC values exceeding 0.8 for 1-year, 3-year, and 5-year survival rates and confirmed in external datasets GSE22138 and GSE84976. Differential gene analysis between risk groups highlighted the association with immune response and cell proliferation functions. The CEBPB gene in the model played crucial roles in tumor progression. In vivo and in vitro experiments validated the impact of CEBPB on the biological functions of UM. Experiments in UM cells revealed that CEBPB promoted cell proliferation, migration and invasion, as well as suppressing apoptosis, indicating its potential as a therapeutic target. The prognostic model based on 8 immune-related genes effectively predicted the survival outcomes of UM. Knockdown of CEBPB significantly reduced the progression of UM, suggesting that it could be a potential therapeutic target for UM.

摘要

葡萄膜黑色素瘤(UM)是一种具有高转移风险的原发性眼内恶性肿瘤。目前,尚无基于免疫相关分子亚型构建预后模型的研究。我们基于癌症基因组图谱 - 葡萄膜黑色素瘤(TCGA - UVM)数据集对免疫细胞浸润矩阵进行无监督聚类,确定了2个具有不同免疫检查点和免疫激活相关基因表达模式的簇。基因本体论/京都基因与基因组百科全书富集分析表明,加权基因共表达网络分析(WGCNA)确定的免疫相关基因模块中的基因与免疫活性和细胞增殖相关。使用基于免疫相关基因模块的Cox和LASSO回归分析构建预后模型。该预后模型在基因表达综合数据库(GEO)的外部数据集中得到验证。我们构建了一个包含S100A4、KCNIP3、PARP8、ORAI2、MMP12、ISG20、MMP9和CEBPB基因的预后模型。该模型将患者分为高风险组和低风险组,高风险组预后较差。该模型的预测准确性通过1年、3年和5年生存率的AUC值超过0.8得到验证,并在外部数据集GSE22138和GSE84976中得到证实。风险组之间的差异基因分析突出了与免疫反应和细胞增殖功能的关联。模型中的CEBPB基因在肿瘤进展中起关键作用。体内和体外实验验证了CEBPB对UM生物学功能的影响。对UM细胞的实验表明,CEBPB促进细胞增殖、迁移和侵袭,并抑制细胞凋亡,表明其作为治疗靶点的潜力。基于8个免疫相关基因的预后模型有效地预测了UM的生存结果。敲低CEBPB显著降低了UM的进展,表明它可能是UM的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/8b38f68bee00/medi-104-e42574-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/a562dbf100fd/medi-104-e42574-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/24196493fba0/medi-104-e42574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/7ba5832e0460/medi-104-e42574-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/d1325571ed43/medi-104-e42574-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/44ca9c6a0ea5/medi-104-e42574-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/8e3d16515e6b/medi-104-e42574-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/95edf9014fbe/medi-104-e42574-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/a21034bca30f/medi-104-e42574-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/8b38f68bee00/medi-104-e42574-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/a562dbf100fd/medi-104-e42574-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/24196493fba0/medi-104-e42574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/7ba5832e0460/medi-104-e42574-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/d1325571ed43/medi-104-e42574-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/44ca9c6a0ea5/medi-104-e42574-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/8e3d16515e6b/medi-104-e42574-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/95edf9014fbe/medi-104-e42574-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/a21034bca30f/medi-104-e42574-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3f/12187318/8b38f68bee00/medi-104-e42574-g009.jpg

相似文献

1
Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational study.葡萄膜黑色素瘤中免疫相关预后模型的构建及CEBPB的功能分析:一项符合STROBE标准的观察性研究。
Medicine (Baltimore). 2025 Jun 20;104(25):e42574. doi: 10.1097/MD.0000000000042574.
2
Construction and validation of a lipid metabolism-related genes prognostic signature for skin cutaneous melanoma.皮肤黑色素瘤脂质代谢相关基因预后特征的构建与验证
Biochem Biophys Res Commun. 2025 May 29;775:152115. doi: 10.1016/j.bbrc.2025.152115.
3
A Golgi apparatus-related signature for predicting prognosis and evaluating the tumor immune microenvironment of uveal melanoma.一种与高尔基体相关的特征,用于预测葡萄膜黑色素瘤的预后和评估肿瘤免疫微环境。
Medicine (Baltimore). 2025 Jun 20;104(25):e42909. doi: 10.1097/MD.0000000000042909.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Elevated Expression in Uveal Melanoma Predicts Poor Patient Prognosis.葡萄膜黑色素瘤中表达升高预示患者预后不良。
Cancer Genomics Proteomics. 2025 Jun 26;22(4):624-631. doi: 10.21873/cgp.20526.
6
Identification and validation of a KRAS-macrophage-associated gene signature as prognostic biomarkers and potential therapeutic targets in melanoma.鉴定和验证一种与KRAS-巨噬细胞相关的基因特征作为黑色素瘤的预后生物标志物和潜在治疗靶点。
Front Immunol. 2025 Jun 18;16:1566432. doi: 10.3389/fimmu.2025.1566432. eCollection 2025.
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.口腔鳞状细胞癌中m6A/m1A/m5C/m7G/ac4C修饰基因的生物信息学鉴定与验证
BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7.
10
Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.整合蛋白质组学和转录组学分析揭示雌激素受体阳性/孕激素受体阳性与雌激素受体阳性/孕激素受体阴性乳腺癌之间的关键调控基因。
BMC Cancer. 2025 Jul 1;25(1):1048. doi: 10.1186/s12885-025-14451-y.

本文引用的文献

1
TGF β1 promotes the polarization of M2-type macrophages and activates PI3K/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin.TGFβ1 通过抑制 ISG20 促进 M2 型巨噬细胞极化并激活 PI3K/mTOR 信号通路,从而使卵巢癌细胞对顺铂敏感。
Int Immunopharmacol. 2024 Jun 15;134:112235. doi: 10.1016/j.intimp.2024.112235. Epub 2024 May 17.
2
Next-generation sequencing of uveal melanoma with clinical and histological correlations: Prognostic value of new mutations in the PI3K/AKT/mTOR pathway.葡萄膜黑色素瘤的下一代测序及其临床与组织学相关性:PI3K/AKT/mTOR通路新突变的预后价值
Clin Exp Ophthalmol. 2023 Nov;51(8):822-834. doi: 10.1111/ceo.14302. Epub 2023 Oct 6.
3
A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
LCN2、LOXL2 和 MMP9 蛋白复合物促进食管癌的肿瘤转移。
Mol Oncol. 2023 Nov;17(11):2451-2471. doi: 10.1002/1878-0261.13529. Epub 2023 Oct 4.
4
A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma.一个新建立的铜死亡相关基因特征可预测葡萄膜黑色素瘤的预后和免疫浸润。
Int J Mol Sci. 2023 Jul 12;24(14):11358. doi: 10.3390/ijms241411358.
5
PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis.PRPF6 通过 SNHG16/CEBPB/GATA3 轴促进卵巢癌的转移和紫杉醇耐药性。
Oncol Res. 2022 Aug 31;29(4):275-289. doi: 10.32604/or.2022.03561. eCollection 2021.
6
Prognostic Values of Gene Copy Number Alterations in Prostate Cancer.前列腺癌中基因拷贝数改变的预后价值。
Genes (Basel). 2023 Apr 22;14(5):956. doi: 10.3390/genes14050956.
7
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors.线粒体在黑色素瘤对 PD-1 抑制剂耐药中的作用。
J Transl Med. 2023 May 23;21(1):345. doi: 10.1186/s12967-023-04200-9.
8
PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients.PI3K/AKT/mTOR信号通路衍生的风险评分与葡萄膜黑色素瘤患者的免疫浸润相关。
Front Oncol. 2023 Apr 20;13:1167930. doi: 10.3389/fonc.2023.1167930. eCollection 2023.
9
Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy.鉴定和验证葡萄膜黑色素瘤中的免疫原性细胞死亡相关评分,以改善预后预测和对免疫治疗的反应。
Aging (Albany NY). 2023 May 3;15(9):3442-3464. doi: 10.18632/aging.204680.
10
YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.YY1 复合物在 M2 巨噬细胞中上调 IL-6 促进前列腺癌进展。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006020.